BTIG Maintains Buy on Neuronetics, Raises Price Target to $6
BTIG analyst Sam Eiber maintains Neuronetics (NASDAQ: STIM ) with a Buy and raises the price target from $5 to $6.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.